C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
01/2003
01/02/2003	US20030004164 Anticancer agents; autoimmune diseases
01/02/2003	US20030004162 Antidiabetic agents; dietetics
01/02/2003	US20030004161 Anticancer agents; autoimmune diseases
01/02/2003	US20030003379 Photoresist monomers, polymers thereof and photoresist compositons containing the same
01/02/2003	EP1270572A1 Condensed pyrazole derivatives, process for producing the same and use thereof
01/02/2003	EP1270567A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof
01/02/2003	EP1270557A1 Ethylenediamine derivatives
01/02/2003	EP1268486A2 Fused heterocyclic derivatives, their production and use
01/02/2003	EP1268437A1 Inhibitors of protein kinases
01/02/2003	EP1268408A1 Arthropodicidal carboxanilides
01/02/2003	EP1267855A2 Vasopeptidase inhibitors to treat isolated systolic hypertension
01/02/2003	EP1073648A4 12,13-modified epothilone derivatives
01/02/2003	EP1073647A4 12,13-cyclopropane epothilone derivatives
01/02/2003	EP1019370B1 Ace-inhibitor nitric salts
12/2002
12/31/2002	US6500958 Carboxylic acid derivatives and process for producing the same
12/31/2002	US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants
12/27/2002	WO2002102806A1 Alicyclic compound for optical material
12/27/2002	WO2002102798A1 Uracil derivative and herbicide composition
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/26/2002	US20020198390 Acrylic esters containing fluorine at alpha-position and having a lactone ring introduced into the ester side chain thereof; useful as monomers to produce base polymers for use in chemically amplified resist compositions
12/26/2002	US20020198384 Thienopyridine derivatives, their intermediates and production thereof
12/26/2002	US20020198339 Process for the preparation of ethylene polymers
12/26/2002	US20020198229 Polymorphic form of clopidogrel hydrogen sulphate
12/26/2002	US20020198191 Cyclohexylphenyl vasopressin agonists
12/26/2002	US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/25/2002	CN1097054C Tricyclic pyrazole derivs. and composition
12/24/2002	US6498251 Tetrahydrobenzindole derivatives
12/24/2002	US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
12/19/2002	WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002	WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/19/2002	WO2002100852A1 Benzothiophene compounds having antiinfective activity
12/19/2002	WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002059128A3 Process for preparing clopidogrel
12/19/2002	WO2002050082A3 Inhibitors of papilloma virus
12/19/2002	WO2001047919A9 Substituted oxazolidinones and their use in the field of blood coagulation
12/19/2002	US20020193611 Oligothiophenes and synthesis thereof
12/19/2002	US20020193418 Methods of using and preparing thiolutin dioxide
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193381 For preventing contractions of the urethra and lower urinary tract, without substantially affecting blood pressure; for blocking alpha 1 receptors
12/19/2002	CA2450628A1 Benzothiophene compounds having antiinfective activity
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/18/2002	EP1266898A1 Processes for the production of thienopyrimidine derivatives
12/18/2002	EP1265903A1 Thiepino[3,2-b]dihydropyridines and related compositions and methods
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1086101B1 Beta-carboline compounds
12/18/2002	EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii)
12/18/2002	EP0646019B9 Biotin-DOTA conjugates and their use in pretargeting methods
12/17/2002	US6495691 Their pharmaceutically acceptable salts, wherein the meaning of x is hydrogen, carboxyl, alkoxycarbonyl, aryloxycarbonyl, nitrile, or carbamoyl of the formula ticlopidine, is an antithrombotic drug with platelet aggregation inhibiting
12/17/2002	US6495683 Herpes virus
12/17/2002	US6495557 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/17/2002	US6495555 Tricyclic Δ-3-piperidines as α2-antagonists
12/17/2002	US6495554 Phosphodiesterase v inhibitors, treating cardiovascular disorders, and therapy of erectile dysfunction.
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/12/2002	WO2002099436A2 Characterising polypeptides
12/12/2002	WO2002098868A1 Epothilone derivatives
12/12/2002	WO2002081398A3 Additives for building industry obtained from by-products and process for their production
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	US20020187994 New compounds
12/12/2002	CA2449681A1 Characterising polypeptides
12/12/2002	CA2449077A1 Epothilone derivatives
12/11/2002	EP1265072A1 Method for characterising polypeptides
12/11/2002	EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002	EP0783555B1 Poly(paraphenylene vinylene) derivatives and their use as electroluminescent materials
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492411 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492383 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
12/10/2002	US6492358 For treatment of sexual disorders, male erectile dysfunction
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096359A2 Piperazine pentanamide hiv protease inhibitors
12/05/2002	WO2002078633A8 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183369 For therapy of diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis
12/05/2002	US20020183337 For use in immunosuppression; for reducing the risk of, a reversible obstructive airways disease
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183310 For therapy or inhibiting osteoporosis or inhibiting bone demineralization, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis in mammal
12/05/2002	US20020182652 Detection of preferential protein in sample; obtain sample of protein mixture, incubate with probe, detect signal from probes
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2411549A1 Ligands of integrin receptors
12/04/2002	EP1261731A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
12/04/2002	EP1261606A1 Substituted oxazolidinones and their use in the field of blood coagulation
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261327A2 Adenosine receptor modulators
12/03/2002	US6489473 Pyrroloazepine derivatives
12/03/2002	US6489351 Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentation induction factor action
12/03/2002	US6489318 Ethylidene derivatives of tricyclic carbapenems
12/03/2002	CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents
11/2002
11/28/2002	WO2002094249A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine for the treatment of pain
11/28/2002	WO2002094187A2 Novel use

1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 214